Related references
Note: Only part of the references are listed.ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer
Shuohui Dong et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2022)
Novel function of THEMIS2 in the enhancement of cancer stemness and chemoresistance by releasing PTP1B from MET
Wei-Chieh Huang et al.
ONCOGENE (2022)
Anhydroicaritin Inhibits EMT in Breast Cancer by Enhancing GPX1 Expression: A Research Based on Sequencing Technologies and Bioinformatics Analysis
Feifei Li et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)
Selenium ameliorates mercuric chloride-induced brain damage through activating BDNF/TrKB/PI3K/AKT and inhibiting NF-κB signaling pathways
Lan-Xin Li et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2022)
Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T cells response
Tristan Rupp et al.
TRANSLATIONAL ONCOLOGY (2022)
Soluble PD-L1 Expression After Intravenous Treatment of Cancer Patients With Selenite in Phase I Clinical Trial
Ali Razaghi et al.
FRONTIERS IN ONCOLOGY (2022)
The Role and Mechanism of Essential Selenoproteins for Homeostasis
Ruihua Ye et al.
ANTIOXIDANTS (2022)
Protective mechanism of selenium on mercuric chloride-induced testis injury in chicken via p38 MAPK/ATF2/iNOS signaling pathway
Xue-Wei Chen et al.
THERIOGENOLOGY (2022)
Selenium Yeast and Fish Oil Combination Diminishes Cancer Stem Cell Traits and Reverses Cisplatin Resistance in A549 Sphere Cells
I-Chun Lai et al.
NUTRIENTS (2022)
Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers
Briana K. Shimada et al.
BIOMOLECULES (2022)
Tackling metastatic triple-negative breast cancer with sacituzumab govitecan
Anna R. Schreiber et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2021)
Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls
Sara Bravaccini et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Blocking Wnt/β-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas
Hui Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
A Pan-Cancer Analysis of the Role of Selenoprotein P mRNA in Tumorigenesis
Yanni Yang et al.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (2021)
Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer
Supriya Bevinakoppamath et al.
FRONTIERS IN PHARMACOLOGY (2021)
Selenium stimulates the antitumour immunity: Insights to future research
Ali Razaghi et al.
EUROPEAN JOURNAL OF CANCER (2021)
Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1
Joohyun Woo et al.
PLOS ONE (2021)
Trop2 binding IGF2R induces gefitinib resistance in NSCLC by remodeling the tumor microenvironment
Xia Sun et al.
JOURNAL OF CANCER (2021)
Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells
Yuhui Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
HIF-1 dependent reversal of cisplatin resistance via anti-oxidative nano selenium for effective cancer therapy
Xiaojuan Zhang et al.
CHEMICAL ENGINEERING JOURNAL (2020)
Expression and prognostic potential of GPX1 in human cancers based on data mining
Rucliong Wei et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Integrated Analysis to Study the Relationship between Tumor-Associated Selenoproteins: Focus on Prostate Cancer
Francesca Capone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
Antonio Marra et al.
NPJ BREAST CANCER (2020)
Identification of CTLA-4 associated with tumor microenvironment and competing interactions in triple negative breast cancer by co-expression network analysis
Ziqi Peng et al.
JOURNAL OF CANCER (2020)
Androgens Induce Invasiveness of Triple Negative Breast Cancer Cells Through AR/Src/PI3-K Complex Assembly
Pia Giovannelli et al.
SCIENTIFIC REPORTS (2019)
Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer-How We Can Rise to the Challenge
Milica Nedeljkovic et al.
CELLS (2019)
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
L. Gerratana et al.
CANCER TREATMENT REVIEWS (2018)
Selenoprotein H controls cell cycle progression and proliferation of human colorectal cancer cells
Martin Bertz et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Anti-Trop2 blockade enhances the therapeutic efficacy of ErbB3 inhibition in head and neck squamous cell carcinoma
Nathan Redlich et al.
CELL DEATH & DISEASE (2018)
Selenium targets resistance biomarkers enhancing efficacy while reducing toxicity of anti-cancer drugs: preclinical and clinical development*
Yousef Zakharia et al.
Oncotarget (2018)
Methylseleninic Acid Sensitizes Ovarian Cancer Cells to T-Cell Mediated Killing by Decreasing PDL1 and VEGF Levels
Deepika Nair et al.
FRONTIERS IN ONCOLOGY (2018)
Insulin-like growth factor receptor signaling in breast tumor epithelium protects cells from endoplasmic reticulum stress and regulates the tumor microenvironment
Alison E. Obr et al.
BREAST CANCER RESEARCH (2018)
TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT
Xinxing Li et al.
ONCOTARGET (2017)
Trop2 enhances invasion of thyroid cancer by inducing MMP2 through ERK and JNK pathways
Hongyu Guan et al.
BMC CANCER (2017)
Biological Subtypes of Triple-Negative Breast Cancer
Michael Hubalek et al.
BREAST CARE (2017)
v-Src Oncogene Induces Trop2 Proteolytic Activation via Cyclin D1
Xiaoming Ju et al.
CANCER RESEARCH (2016)
Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer
Nadine Tung et al.
NPJ BREAST CANCER (2016)
Effects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells
Chih-Hung Guo et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2015)
Supplementation with Selenium yeast on the prooxidant-antioxidant activities and anti-tumor effects in breast tumor xenograft-bearing mice
Chih-Hung Guo et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2015)
The role of the insulin-like growth factor-1 system in breast cancer
Panagiotis F. Christopoulos et al.
MOLECULAR CANCER (2015)
Phospho-kinase profile of triple negative breast cancer and androgen receptor signaling
Maria D. Cuenca-Lopez et al.
BMC CANCER (2014)
N-Linked Glycosylation Supports Cross-Talk between Receptor Tyrosine Kinases and Androgen Receptor
Harri M. Itkonen et al.
PLOS ONE (2013)
Selenium Metabolism in Cancer Cells: The Combined Application of XAS and XFM Techniques to the Problem of Selenium Speciation in Biological Systems
Claire M. Weekley et al.
NUTRIENTS (2013)
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibition
Sreenivasulu Chintala et al.
BMC CANCER (2012)
Insulin-like Growth Factor-Dependent Proliferation and Survival of Triple-Negative Breast Cancer Cells: Implications for Therapy
Zoe Davison et al.
NEOPLASIA (2011)
Selenium as an anticancer nutrient: roles in cell proliferation and tumor cell invasion
Huawei Zeng et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2008)
Inhibition of androgen receptor signaling by selenite and methylseleninic acid in prostate cancer cells: two distinct mechanisms of action
Bryan Husbeck et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Mechanisms of selenium down-regulation of androgen receptor signaling in prostate cancer
JY Chun et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Androgens up-regulate the insulin-like growth factor-I receptor in prostate cancer cells
G Pandini et al.
CANCER RESEARCH (2005)